DNA Repair
GSK walks away from remaining IDEAYA programs, formally ending partnership
GSK; IDEAYA Biosciences; synthetic lethality; collaboration termination; Werner helicase; Pol Theta; DNA damage repair; oncology partnership; license agreement; drug development pipeline